CAC
AVDL
Cowen and Company’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,642,347
| Closed | -$23.2M | – | 608 |
|
|
2023
Q4 | $23.2M | Sell |
1,642,347
-695,955
| -30% | -$9.83M | 1.52% | 19 |
|
|
2023
Q3 | $24.1M | Sell |
2,338,302
-325,774
| -12% | -$3.36M | 1.69% | 12 |
|
|
2023
Q2 | $43.9M | Sell |
2,664,076
-1,068,702
| -29% | -$17.6M | 3.64% | 6 |
|
|
2023
Q1 | $34.2M | Hold |
3,732,778
| – | – | 4.02% | 4 |
|
|
2022
Q4 | $26.7M | Hold |
3,732,778
| – | – | 2.79% | 11 |
|
|
2022
Q3 | $18.7M | Hold |
3,732,778
| – | – | 1.79% | 18 |
|
|
2022
Q2 | $9.11M | Hold |
3,732,778
| – | – | 0.88% | 28 |
|
|
2022
Q1 | $25.5M | Hold |
3,732,778
| – | – | 2.45% | 12 |
|
|
2021
Q4 | $30.2M | Buy |
3,732,778
+1,207,326
| +48% | +$9.76M | 2.74% | 7 |
|
|
2021
Q3 | $24.7M | Buy |
2,525,452
+29,879
| +1% | +$293K | 1.17% | 18 |
|
|
2021
Q2 | $16.8M | Hold |
2,495,573
| – | – | 0.88% | 18 |
|
|
2021
Q1 | $22.6M | Buy |
2,495,573
+603,530
| +32% | +$5.46M | 1.55% | 11 |
|
|
2020
Q4 | $12.6M | Sell |
1,892,043
-13,947
| -0.7% | -$93.2K | 1.13% | 14 |
|
|
2020
Q3 | $9.61M | Sell |
1,905,990
-1,514
| -0.1% | -$7.63K | 1.57% | 10 |
|
|
2020
Q2 | $15.4M | Buy |
1,907,504
+390,208
| +26% | +$3.15M | 2.56% | 6 |
|
|
2020
Q1 | $10.8M | Buy |
+1,517,296
| New | +$10.8M | 2.47% | 7 |
|